Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • minhduc
    Junior Member
    • Apr 2012
    • 5

    #1

    Help!! Interpret MoDIL results.

    Hi,
    I have been running to MoDIL to locate indels and have problems interpreting the output. According to the README file
    Results format is:

    - Cluster ID: Unique ID for each indel prediction
    - Chromosome: Chromosome where the indel is located.
    - Start location: Start location of indel
    - End location: End location of indel
    - Insertion flag: If it is 1, the row means insertion, deletion otherwise.
    - Deletion flag: If it is 1, the row means deletion, insertion otherwise.
    - Size of indel: If it is negative it means deletion, insertion otherwise.
    (ex) -300 => 300bp deletion
    (ex) 12 => 12bp insertion
    - P value: P-value of the indel prediction
    - Likelihood of homozygosity: If it is homozygous, it is close to 1.
    - Number of matepairs that support indel
    - Number of matepairs that support no indel: If it is zero, the indel
    is homozygous
    and an excerpt from the predicted INDELs in Yoruban genome from MoDIL website:
    1.0 chr1 218651814 218652002 1 0 75.0 0 1e-09 21220038 0 47 0 25 36 218651906 218651972
    1.0 chr1 102759676 102760211 0 1 -329.0 0 1e-09 10323514 0 67 0 32 37 102759712 102760037
    I'd interpret the above results as a 75pb insertion starting at pos 218651814 ending at 218652002, and a 329bp deletion from 102759676 to 102760211. I do not understand how an insertion of size 75bp can start at 218651814 and end at 218652002 (i.e., 188 bp apart)? Likewise, in the second line, how a deletion from 102759676 to 102760211 (535 bp in between) can be a 329pb deletion? Could anyone help to explain or to point out what is wrong with my interpretation?

    Many thanks
    MD

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
32 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Working...